Search

Your search keyword '"Gordon, Ingelise J"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Gordon, Ingelise J" Remove constraint Author: "Gordon, Ingelise J" Database Unpaywall Remove constraint Database: Unpaywall
22 results on '"Gordon, Ingelise J"'

Search Results

1. Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial

2. Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial

3. Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial

4. Clonal hematopoiesis is not significantly associated with COVID-19 disease severity

5. Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria

6. Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial

7. Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial

8. A Monoclonal Antibody for Malaria Prevention

9. Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants

10. Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants

11. Functional Profiling of Antibody Immune Repertoires in Convalescent Zika Virus Disease Patients

12. Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial

13. Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study

14. Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

15. An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial

16. Chimpanzee Adenovirus Vector Ebola Vaccine

17. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection

18. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

19. DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials

20. A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial

21. A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial

22. Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax® challenge in vaccinia-naïve and vaccinia-immune individuals

Catalog

Books, media, physical & digital resources